Clinical Trial

The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocardial Infarction - A Single-Centre Randomized Control Trial

Study acronym: ELITE-STEMI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn the effect of low level tragus stimulation (LLTS) on echocardiographic parameter in patient with ST-segment Elevation Myocardial Infarction (STEMI) who undergo primart percutaneous coronary intervention (PPCI). It will also learn about the safety of LLTS in such setting. The main questions, it aims to answer are compared with sham control: Does LLTS could alter left ventricular ejection fraction in patients with STEMI? Does LLTS could alter wall motion score index in patients with STEMI? Does LLTS could alter diastolic dysfunction in patients with STEMI? Researchers will compare LLTS to sham LLTS control to see if LLTS have benefit in participants with STEMI participants will divided into two group i.e. treatment group vs control (sham/placebo) group.. Both groups undergo transthoracal echocardiographi examination before and after PPCI..
Trial Details
NCT Number NCT07058857
Lead Sponsor Universitas Diponegoro
Conditions ST Elevation Myocardial Infarction
Enrollment 100 participants
Start Date 2025-01-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-10